Similar Items: Sintilimab-Induced Sequential Multi-System Severe Immune-Related Adverse Events in an Elderly Patient with Esophageal Squamous Cell Carcinoma: A Case Report and Literature Review
- Nanoparticle polymeric micellar paclitaxel compared with paclitaxel for advanced esophageal squamous cell carcinoma
- HK2/VDAC1 Axis Regulates Malignant Progression of Esophageal Squamous Cell Carcinoma
- Revisiting Thoracic Duct Resection in Esophageal Squamous Cell Carcinoma: A Propensity‐Matched Analysis and Immunologic Insight Into Recurrence Risk
- Neoadjuvant versus adjuvant chemoradiotherapy for resectable cT3‐4a esophageal squamous cell carcinoma: A matched cohort analysis
- Elevation of Eosinophil Proportion After Pembrolizumab Increases the Risk of Immune‐Related Adverse Events in Patients With Bladder Cancer
- Advances in mucosal injury mechanisms in radiation‐induced esophagitis associated with thoracic radiotherapy